
In this area our teams are elucidating the biochemical and cellular basis of human diseases and the molecular mechanisms underlying drug action and their targets.
Our investigation of disease mechanisms provides insights into identification of novel therapeutic targets for which small molecules or biologics are being developed. Research is directed towards the molecular and cellular mechanisms underlying the function of therapeutic targets, correcting the target using gene therapy, and the intracellular signalling pathways they control and the mechanistic study of drug action. Approaches incorporate human studies, patient-derived samples and animal models of disease. Our research teams are interested in several human diseases or conditions including drug addiction, autism, diabetes, cancer, genetic disorders, infectious diseases, and neurological diseases.
Investigators
Research News
Image

PharmD student receives Volunteer Award from Life Sciences Ontario
Simonne Rauch is recognized for her contributions to ambassador and mentorship programs.
Read More
Image

Celebrating Excellence: Mike Folinas Receives 2024-25 Exemplary U of T Ambassador Award
Mike Folinas has received the 2024–25 Exemplary U of T Ambassador Award for his outstanding service and leadership in supporting the academic community.
Read More
Image

Structural biology research takes aim at rare neurodegenerative disease
Rachel Harding leads research to understand protein responsible for Huntington’s disease and advance drug discovery
Read More